Insider Trading: Optimer Pharmaceuticals Inc (OPTR.O)
OPTR.O on Nasdaq
14.84USD
10:01am EDT
14.84USD
10:01am EDT
Price Change (% chg)
$0.14 (+0.95%)
$0.14 (+0.95%)
Prev Close
$14.97
$14.97
Open
$14.75
$14.75
Day's High
$14.93
$14.93
Day's Low
$14.66
$14.66
Volume
92,638
92,638
Avg. Vol
1,009,343
1,009,343
52-wk High
$16.80
$16.80
52-wk Low
$8.64
$8.64
| CHANG MICHAEL N | Options Exercised: 0 | ||
| Trade Date: | Saturday, 31 Dec 2011 | Price: | 0.00 |
| Title: | Director | Shares Held: | 821,402 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 5,000 |
Institutional Holders
| % Shares Owned: | 90.50% |
| # of Holders: | 134 |
| Total Shares Held: | 44,091,156 |
| 3 Mo. Net Change: | 2,145,365 |
| # New Positions: | 20 |
| # Closed Positions: | 18 |
| # Increased Positions: | 61 |
| # Reduced Positions: | 54 |
| # Net Buyers: | 7 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Henry McKinnell |
70 | 2013 | Chairman of the Board, Chief Executive Officer |
Stephen Webster |
51 | 2012 | Chief Financial Officer and Principal Financial and Accounting Officer |
Eric Sirota |
51 | 2013 | Chief Operating Officer |
Sherwood Gorbach |
77 | 2011 | Senior Vice President, Chief Scientific Officer |
Linda Amper |
55 | 2011 | Senior Vice President - Human Resources |
Meredith Schaum |
2013 | Chief Compliance Officer, General Counsel, Secretary | |
Mark Auerbach |
2013 | Lead Independent Director | |
Michael Chang |
61 | 2012 | Director |
Stephen Newman |
62 | 2012 | Director |
Anthony Altig |
56 | 2007 | Independent Director |
Joseph Chang |
60 | 2012 | Independent Director |
Peter Grebow |
65 | 2009 | Independent Director |
Robert Zerbe |
61 | 2009 | Independent Director |
David Walsey |
VP - Investor Relations & Corporate Communications |

